End-Stage renal disease and 30-day mortality for adults with and without COVID-19

Stephanie L. Harrison; Benjamin J.R. Buckley; Elnara Fazio-Eynullayeva; Paula Underhill; Deirdre A. Lane; Gregory Y.H. Lip

doi:10.1016/j.ejim.2020.11.003

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

Stephanie L. Harrison, Benjamin J.R. Buckley, Elnara Fazio-Eynullayeva, Paula Underhill, Deirdre A. Lane, Gregory Y.H. Lip

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	93-95
Number of pages	3
Journal	European Journal of Internal Medicine
Volume	83
DOIs	https://doi.org/10.1016/j.ejim.2020.11.003
Publication status	Published or Issued - Jan 2021
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1016/j.ejim.2020.11.003

Cite this

@article{2d2cbf7543be495b825d16c8d297119d,

title = "End-Stage renal disease and 30-day mortality for adults with and without COVID-19",

author = "Harrison, {Stephanie L.} and Buckley, {Benjamin J.R.} and Elnara Fazio-Eynullayeva and Paula Underhill and Lane, {Deirdre A.} and Lip, {Gregory Y.H.}",

note = "Funding Information: Stephanie L Harrison and Benjamin JR Buckley: None declared. Elnara Fazio-Eynullayeva and Paula Underhill are employees of TriNetX Inc. Deirdre A Lane has received investigator-initiated educational grants from Bristol-Myers Squibb (BMS), has been a speaker for Boehringer Ingeheim, and BMS/Pfizer and has consulted for BMS, Boehringer Ingelheim, and Daiichi-Sankyo. Gregory YH Lip: consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo and speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received to Gregory Lip personally. ",

year = "2021",

month = jan,

doi = "10.1016/j.ejim.2020.11.003",

language = "English",

volume = "83",

pages = "93--95",

journal = "European Journal of Internal Medicine",

issn = "0953-6205",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - End-Stage renal disease and 30-day mortality for adults with and without COVID-19

AU - Harrison, Stephanie L.

AU - Buckley, Benjamin J.R.

AU - Fazio-Eynullayeva, Elnara

AU - Underhill, Paula

AU - Lane, Deirdre A.

AU - Lip, Gregory Y.H.

N1 - Funding Information: Stephanie L Harrison and Benjamin JR Buckley: None declared. Elnara Fazio-Eynullayeva and Paula Underhill are employees of TriNetX Inc. Deirdre A Lane has received investigator-initiated educational grants from Bristol-Myers Squibb (BMS), has been a speaker for Boehringer Ingeheim, and BMS/Pfizer and has consulted for BMS, Boehringer Ingelheim, and Daiichi-Sankyo. Gregory YH Lip: consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo and speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received to Gregory Lip personally.

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85096873532&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2020.11.003

DO - 10.1016/j.ejim.2020.11.003

M3 - Letter

C2 - 33187792

AN - SCOPUS:85096873532

SN - 0953-6205

VL - 83

SP - 93

EP - 95

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

ER -

End-Stage renal disease and 30-day mortality for adults with and without COVID-19

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this